A feasibility study for salvage radiation therapy in prostate cancer.". To design the salvage radiation therapy, imaging is required to detect and locate the recurrence disease regime," the researchers write.
Recent studies, including the Phase II/III randomized controlled trial, Emory Molecular Prostate Imaging for Radiotherapy Enhancement , demonstrated improved biochemical recurrence or persistence free survival rates when incorporating 18F-fluciclovine PET/CT into post-prostatectomy radiation therapy planning.
: A feasibility study for salvage radiation therapy in prostate cancer retrieved 1 July 2024 from https://medicalxpress.com/news/2024-07-feasibility-salvage-therapy-prostate-cancer.html